 Richard Walovitch, Ph.D. WorldCare Clinical Chief Medical Officer Visit Website |
Dr. Walovitch is chief medical officer of WorldCare Clinical. Prior to joining WCC, he served as the senior vice president of clinical research at Acusphere, Inc., vice president of preclinical and clinical research at Epix Medical, and research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. Walovitch has a doctorate in pharmacology from the University of Illinois Medical Center and a bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
|
Imaging Q&A
-
With so many disciplines involved, what unique training and background should be required for clinical molecular imagers?Answered April 8th, 2010 by Expert:The curriculum in clinical molecular imaging usually emphasizes these major components:
1) PET
2) Radioimmunotherapy and
3) Structural imaging
When working with these state-of-the-art techniques, it is important to evaluate the application of imaging in the management of multiple disease states. Here at WorldCare Clinical, our clinical trials encompass a wide diversity of radiopharmaceuticals in pursuing therapeutics for diseases where there are none.
Leave a reply